CClinicalTrials.gg
Status unknownNCT01385514Updated Mar 23, 2012

Staphylococcus Aureus Skin and Soft Tissue Infections

An observational study in Staphylococcus Aureus, sponsored by Medical Corps, Israel Defense Force. Status unknown at 1 site in Israel. Open to male participants aged 18 Years to 25 Years, including healthy volunteers. Per ClinicalTrials.gov, last updated 2012-03-23.

Sponsored by Medical Corps, Israel Defense Force · Observational

The sponsor has not verified this record recently (last verified Mar 2012), so the status shown — last known as Recruiting — may be out of date.
Study type
Observational
Model
Cohort
Time perspective
Prospective
Enrollment
1,050
Ages
18 Years to 25 Years
Sex
Male
01

Study summary

The purpose of this study is to evaluate strategies to prevent Staphylococcus aureus skin and soft tissue infections in soldiers during infantry training.

This study will be conducted on three different bases among groups of male recruits to IDF training base. They will provide nasal swabs to detect Staphylococcus aureus carriage in two time points: 1. before mixing and training in confined settings, reflecting carriage acquired before entering 2. After 14-30 days. All soldiers will be under surveillance for skin infection until the end of the training program.

02

Conditions studied

  • Staphylococcus Aureus
03

In context

Staphylococcal Infections

273 studies on the registry are indexed under Staphylococcal Infections; 29 are open to participants now.

This study's planned enrollment of 1,050 is above the median of 200 across 81 observational studies indexed under Staphylococcal Infections.

Browse Staphylococcal Infections studies →

Lead sponsor

Medical Corps, Israel Defense Force is the lead sponsor of 33 studies on the registry; 3 are open to participants now.

Counted across the registry records on this site, refreshed daily.

04

Who can participate

Ages eligible
18 Years to 25 Years
Sexes eligible
Male
Accepts healthy volunteers
Yes
Sampling method
Non-probability sample

Study population

the population of the study will be selected from infantry training bases in the IDF

Eligibility criteria

Inclusion Criteria:

  • new recruit for a combat training unit
05

Study design

Observational model
Cohort
Time perspective
Prospective
Enrollment
1,050 participants (estimated)
Biospecimen retention
Samples without dna

Groups and cohorts

  • company A-Training Base No.1
  • company A-Training Base No.2
  • company A-Training Base No.3
06

Study locations

1 of 1 sites recruiting
  • Israeli Defense Forces
    Tel aviv, Israel
    Recruiting
07

Updates

Tracking since Sep 25, 2026
No changes since tracking began. The registry record was last updated on Mar 23, 2012, before this site started recording changes on Sep 25, 2026. Its history is on ClinicalTrials.gov ↗
08

Registry details

Key details

Study ID
NCT01385514
Lead sponsor
Medical Corps, Israel Defense Force
Responsible party
Sponsor
First posted
Jun 30, 2011
Start date
Jul 2011
Completion
Dec 2013 (estimated)
Last update
Mar 23, 2012

Study contacts

Michael Hartal, MD
Contact
Mhuerta2@gmail.com
+972-3-7374137
Michael Hartal, MD
principal investigator · International Diabetes Federation

Oversight

Data monitoring committee
No
View the source record on ClinicalTrials.gov ↗

Not currently enrolling

This study is status unknown, as verified in Mar 2012. You cannot join it, but the record below documents what was studied.

Follow this study

Get an email when the registry record changes — status, dates, results — or when someone posts here.

Sign in to follow

Discussion

Questions and observations about this study, from anyone following it. Not medical advice, and not a channel to the study team — their contact details are on the registry record.

Sign in to join the discussion. Reading takes no account; posting does. You choose a display name, and a pseudonym is the default.

Nothing here yet. If you are running this trial, taking part in it, or weighing whether to, this is the place to say so.

Start the discussion